USA - NASDAQ:OSRH - US68840D1028 - Common Stock
The current stock price of OSRH is 0.547 USD. In the past month the price decreased by -25.74%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 21.64 | 404.77B | ||
AMGN | AMGEN INC | 13.47 | 158.20B | ||
GILD | GILEAD SCIENCES INC | 15.31 | 147.01B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 24.33 | 105.69B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 61.52B | ||
REGN | REGENERON PHARMACEUTICALS | 12.55 | 60.69B | ||
ARGX | ARGENX SE - ADR | 87.7 | 49.75B | ||
ONC | BEONE MEDICINES LTD-ADR | 5.19 | 35.25B | ||
INSM | INSMED INC | N/A | 34.11B | ||
BNTX | BIONTECH SE-ADR | N/A | 24.67B | ||
NTRA | NATERA INC | N/A | 23.72B | ||
BIIB | BIOGEN INC | 9.08 | 21.30B |
OSR Holdings, Inc. operates as a blank check company. The company is headquartered in Bellevue, Washington. The company went IPO on 2023-02-10. The firm is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The firm's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company’s subsidiary, Vaximm’s flagship asset, VXM01, is a late clinical-stage (NCT037500701) immuno-oncology candidate for glioblastoma. Vaximm has three clinical and pre-clinical drug candidates targeting diseases ranging from glioblastoma to gastrointestinal stromal tumor to ocular diseases. The firm has operations in Europe and South Korea.
OSR HOLDINGS INC
10900 Ne 4Th Street, Suite 2300
Bellevue WASHINGTON US
Employees: 0
Phone: 14256357700
The current stock price of OSRH is 0.547 USD. The price decreased by -3.01% in the last trading session.
The exchange symbol of OSR HOLDINGS INC is OSRH and it is listed on the Nasdaq exchange.
OSRH stock is listed on the Nasdaq exchange.
OSR HOLDINGS INC (OSRH) has a market capitalization of 11.81M USD. This makes OSRH a Nano Cap stock.
OSR HOLDINGS INC (OSRH) currently has 0 employees.
OSR HOLDINGS INC (OSRH) has a support level at 0.54 and a resistance level at 0.55. Check the full technical report for a detailed analysis of OSRH support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
OSRH does not pay a dividend.
OSR HOLDINGS INC (OSRH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.69).
The outstanding short interest for OSR HOLDINGS INC (OSRH) is 1.02% of its float. Check the ownership tab for more information on the OSRH short interest.
ChartMill assigns a fundamental rating of 1 / 10 to OSRH. OSRH has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months OSRH reported a non-GAAP Earnings per Share(EPS) of -1.69. The EPS decreased by -298.8% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -7.18% | ||
ROE | -15.91% | ||
Debt/Equity | 0.05 |